Skip to: Content
Skip to: Site Navigation
Skip to: Search

December 2, 2008 6:33:51 AM CST



FDA Warned of Avandia Risks Years Ago

Posted May 24, 07 1:56 PM CDT in Business Science & Health 

(Newser) – A diabetes doctor warned the FDA of heart risks posed by the diabetes drug Avandia seven years ago, the New York Times reports. The same concerns raised by Dr. John Buse in a 2000 letter were reiterated in a study published by cardiologist Steven Nissen this week.

Documents show that the FDA subsequently reprimanded the drug's maker, GlaxoSmithKline, for minimizing risks. In an interview with the Times, Dr. Buse sticks to his assessment of Avandia, but adds that there should not be a rush to pull it from the market until more studies are completed. “In the last several years, there has not been a study that’s made me feel better about this," he says.

Source New York Times

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon
This undated photo provided by the Cleveland Clinic shows the Cleveland Clinic's cardiology chief, Dr. Steven Nissen. Research by Dr. Nissen has helped keep four dangerous drugs out of the public's hands...   (Associated Press)
« Prev« Prev | Next »Next » Slideshow

Threads (
1
 of 4)



Loading...

Premium Articles from HighBeam

Find more articles like this

Today's Most Popular

Loading...

Other Home Stories


What is Newser?

2008 Codie Finalist

Face it: there's too much news. At Newser a team of editors and writers culls the most important stories from hundreds of U.S. and international sources and reduces them to a headline, picture, and two paragraphs. It's the Newser guarantee: we can take any report or column or video and pack what you need to know into 120 words or less. Newser's short-form aggregation, visual format, and unique information tools help you get more of the kind of news you want, in a quicker and more entertaining way. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »